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a b s t r a c t
Metabolic homeostasis, or low-level metabolic steady state, has long been taken for granted in metabolic
engineering, and research priority has always been given to understand metabolic ﬂux control and
regulation of the reaction network. In the past, this has not caused concerns because the metabolic
networks studied were invariably associated with living cells. Nowadays, there are needs to reconstruct
metabolic networks, and so metabolic homeostasis cannot be taken for granted. For metabolic steady
state, enzyme feedback control has been known to explain why metabolites in metabolic pathways can
avoid accumulation. However, we reasoned that there are further contributing mechanisms. As a new
methodology developed, we separated cofactor intermediates (CIs) from non-cofactor intermediates, and
identiﬁed an appropriate type of open systems for operating putative reaction topologies. Furthermore,
we elaborated the criteria to tell if a multi-enzyme over-all reaction path is of in vivo nature or not at the
metabolic level. As new ﬁndings, we discovered that there are interactions between the enzyme feedback
inhibition and the CI turnover, and such interactions may well lead to metabolic homeostasis, an
emergent property of the system. To conclude, this work offers a new perspective for understanding the
role of CIs and the presence of metabolic homeostasis in the living cell. In perspective, this work might
provide clues for constructing non-natural metabolic networks using multi-enzyme reactions or by
degenerating metabolic reaction networks from the living cell.
& 2016 International Metabolic Engineering Society. Published by Elsevier B.V. International Metabolic
Engineering Society. All rights reserved.
1. Introduction
Metabolic reaction networks entail thousands of enzymes and
connect to a myriad of metabolites, with intermediate number
being of the order of 103 and average concentration 32 μM for a
prokaryote (Atkinson, 1968; Palsson, 2011). A remarkable feature
of such networked reaction system is that all the intracellular
metabolic intermediates (or internal metabolites) are kept at
metabolic homeostasis (in a physiological term) or low level
steady state (in an engineering-orientated term). Such networks
have been observed to be inherently robust (Stephanopoulos and
Vallino, 1991; Ishii et al., 2007; De la Fuente et al., 2014), pre-
dominantly operated at thermodynamic non-equilibrium (Prigo-
gine, 1955; Fell, 1997), and are able to accommodate a widely
varied metabolic ﬂuxes (Stephanopoulos, 1998; Villadsen, 2016).
Metabolic control and regulation take place notably at
metabolic and gene-expression levels (Reich and Sel’kov, 1981;
Palsson, 2015). The time constant (or time scale) can be used to
differentiate study regimes (Palsson, 2011; Reich and Sel’kov,
1981). Control and regulation at metabolic level is a spontaneous,
dynamic reaction process. Representative time constants at this
level are in the range of 0.1–10 s (Reich and Sel’kov, 1981; Wie-
chert, 2002). In contrast, gene-expression and transcriptional
control and regulation regimes for remapping metabolic ﬂuxes
involve biosynthesis/biodegradation of large molecules (e.g. en-
zymes), and their typical time constants are 41 h (Wiechert,
2002; Palsson, 2011). The present work concerns with the control
and regulation at the metabolic level with small time constants.
An important milestone in understanding metabolic regulation
at metabolic level came from the discovery of enzyme negative
feedback control by inhibition (Umbarger, 1956; Yates and Pardee,
1956; Gerhart and Pardee, 1962). Supported by mechanism ex-
plorations, such feedback control mechanism largely avoids me-
tabolite build-up (Monod et al., 1963; Savageau, 1969, 1974;
Chandra et al., 2011; He et al., 2013). The most efﬁcient feedback
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control for a linear pathway at metabolic level is end-product in-
hibition, which may be termed as the optimal design of feedback
inhibition control (Savageau, 1974). It is optimal because such
feedback control requires only one inhibition for a linear carbon-
backbone pathway (Fig. 1(A)), and at least 3 feedback inhibition
loops for a bifurcated pathway system (Fig. 1(B)) (Savageau, 1974,
1976). Even in the case that this mechanism is not functioning, the
cell can still use a contingency mechanism to enzymatically hy-
drolyse the end-product to avoid its build-up (Reaves et al., 2013).
Nevertheless, spontaneous establishment of metabolic home-
ostasis does not rely only on allosteric enzyme regulation me-
chanisms. Morowitz et al. were probably the ﬁrst in reporting the
very nature of such autonomous homeostasis – in their wording
“passive stability in a metabolic network” (Morowitz et al., 1964).
These authors attributed a number of factors to the occurrence of
metabolic homeostasis. Among their claims, the role of carbon
backbone topology has been well substantiated (Morowitz et al.,
2000; Smith and Morowitz, 2004), but the role of the cofactor
topology, superimposed onto the carbon backbone topology, has
never been evidenced.
As a broad objective, this work is aimed to shed light for un-
derstanding why a metabolic network is stable and why all me-
tabolite concentrations are kept at low levels. With low level
steady state being taken for granted, up to now the metabolic
control and regulation community has given priorities to under-
standing how metabolic ﬂuxes are amenable to changes in mag-
nitude and distribution (Hofmeyr and Cornish-Bowden, 1991).
Such convention had been directed to curate genome-based me-
tabolic reaction networks without involving metabolite con-
centrations (Palsson, 2015). Understanding of metabolic home-
ostasis observed for living cells (Savageau, 1976) has long been
separated from research on metabolic ﬂux control and regulation
(Kacser and Burns, 1973; Heinrich and Rapoport, 1974). In the past,
this arbitrary separation had not caused concerns because the
metabolic networks investigated were invariably associated with
living cells where metabolic homeostasis is out of question.
Nowadays, there are challenging needs for reconstructing meta-
bolic networks in synthetic biology or metabolic engineering. In
contrast, metabolic homeostasis for multi-enzyme reaction sys-
tems under investigation can no longer be taken for granted
(Rollin et al., 2015; Keller et al., 2016). In detail, the present work
will describe an emergent property resulted from interactions
between cofactor intermediate (CIs) turnovers and enzyme feed-
back inhibition. This property may play a pivotal role to the
emergence of metabolic homeostasis.
2. Theoretical framework
In order to unfold this research, we ﬁrst separated CIs from
non-cofactor intermediates (NCIs) to reveal the important role of
the CIs, and then conceptually connect the systems used to various
multi-enzyme reaction systems. We quantitatively illustrated how
the metabolic homeostasis of in vivo systems is robust against an
environmental perturbation (i.e. substrate concentration varia-
tion). This outcome then guided us in validating a suitable type of
working open systems.
2.1. CIs versus NCIs
The metabolic network entails 2 types of internal metabolites:
(i) a limited number of paired or grouped CIs and (ii) a vast
number of standalone NCIs. Enzymes utilise NCIs for stepwise
chemical conversion from substrate(s) to desired end products. CIs
are usually paired and each paired CI pool size is ﬁxed for global
uses at the metabolic level. Common CI pairs/groups include ATP/
ADP/AMP (for energy transduction), NADþ/NADH, NADPþ/
NADPH, Q/QH2 (for redox transfer), and CoA-SH/acetyl-CoA/mal-
onyl-CoA/succinyl-CoA (for carbon chain translocation). The en-
ergy CI pool should be referred to as ATPþADPþAMPþPi at the
metabolic reaction time scale (Wiechert, 2002). The catabolic and
anabolic redox CIs pool sizes are NADþþNADH and
NADPþþNADPH respectively. The CoA-related CI pool size is the
sum of CoASH in free form and covalently bound to certain carbon
backbone chains (e.g. acetyl-CoA). Hence, the CoA-bound meta-
bolites are both CIs and NCIs. Besides, metabolism contains further
unique reaction topologies comparable to CI turnovers. For in-
stance, cyclic-like reactions for transferring nitrogen-containing
groups are different in that there is a net consumption of e.g. NH2
groups.
Each CI pool size is inherently small (e.g. ATPþADPþAMP pool
typically at 2 mM) (Atkinson, 1977; Palsson, 2011). To simulta-
neously sustain so many reactions in a homogeneous space, ATP
(ADP) has no options but to turn around at globally balanced rates
through numerous ATP (ADP)-consuming and generating reac-
tions. Usually, an NCI conversion reaction is realised by utilising a
CI as the second reactant. In such network topologies, each CI [e.g.
B (Q) out of the B þ Q pool, Fig. 2(A)–(C)] can only stay either in
steady or oscillating status (Chassagnole, 2002; De la Fuente et al.,
2014). At such metabolic homeostasis, the net B-to-Q or Q-to-B
ﬂux can be termed as CI turnover ﬂux or CI ﬂux. To make a dis-
tinction, the well-understood carbon backbone ﬂux (Stephano-
poulos et al., 1998; Villadsen, 2016) can thus be termed as NCI ﬂux.
Each reaction stoichiometry connects a CI ﬂux to relevant NCI ﬂux
(es). Without metabolic homeostasis, any discussions on ﬂuxes
will become groundless and meaningless. This work underpins
how metabolic homeostasis may be constructed from scratch, and
metabolic ﬂux regulation is not the focus.
2.2. The in-vivo-like system
In the synthetic biology era, the boundary separating an in vivo
and an in vitro systems is becoming more and more blurred. In
order to discuss this subject systematically, it is useful to deﬁne a
new concept termed the in-vivo-like system. In the present con-
text, it refers to a multi-enzyme reaction system which possesses
CI turnover and metabolic homeostasis. Such a system can be ei-
ther completely man-made, or derived from native cells. Indeed,
Fig. 1. End-product feedback control by the minimal inhibition loops for (A) linear
pathway with only one inhibition loop, and (B) bifurcated pathway with 3 inhibi-
tion loops.
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new frontiers of metabolic engineering such as cofactor en-
gineering have been researched for years (San et al., 2002; Rollin
et al., 2015). In this work, we developed a new theory to tell if a
multi-enzyme reaction is an in-vivo-like system or not.
To reveal system wide properties of CIs in a multi-enzyme re-
action system, the 1st network type for this work is composed of
2 parallel linear carbon backbone pathways (Fig. 2(A)–(C)), and the
2nd branched pathways (Fig. 2(D)). In the living cell, all the carbon
Fig. 2. Exempliﬁed metabolic network topologies used in the present study. The broken arrowed line represents negative feedback enzyme inhibition. A: A pair of linear
pathways with the end-product inhibition. S1 & S2 are substrates, P1 & P2 products, Y1, Y2,Y3, Y4, Y5, Y6 NCIs, B & Q CIs in (A). 2 pathways in (B) are disconnected, so B
(Q) becomes substrate and product. B: A pair of linear pathways with the cross-pathway end-product inhibition. S1 & S2 are substrates, P1 & P2 products, Y1, Y2, Y3, Y4, Y5, Y6
NCIs, and B & Q CIs. No in vitro reference reactions. C: A pair of linear pathways with substrate inhibition. S1 & S2 are substrates, P1 & P2 products, Y1, Y2,Y3, Y4, Y5, Y6 NCIs, and
B & Q CIs in (A). 2 pathways in (B) are disconnected, so B (Q) becomes substrate and product. D: Branch network with the end-product inhibition. S1 is substrate, P1, P2 & X
products, Y1, Y2,Y3, Y4, Y5, Y6, Y7, Y8, Y9, Y10, Y11 & Y12 NCIs, B1/Q1 and B2/Q2 CIs. No in vitro reference reactions.
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backbone pathways are ultimately connected. A pair of linear
pathways can thus be viewed to represent those scenarios where
the only link between 2 pathways is via CI turnover. Consequently,
focus in Fig. 2(A)–(C) has been given to the CI-related reaction
network topologies. To avoid concentrations of the 2 substrates
becoming disparate (Fig. 2(A)–(C)), kinetic parameters and enzyme
loadings have been arranged symmetrically for the 2 pathways.
Fig. 2(A) is conﬁgured so that product of the 1st pathway exerts
inhibition on its 1st enzyme whilst the 2nd pathway is free from
inhibition. In addition to the end-product inhibition on the same
pathway (Fig. 2(A)), it is common that product of another see-
mingly unrelated pathway (i.e. the 2nd pathway) can also exert
inhibition over that pathway (i.e. the 1st pathway). This scenario is
presented by the Fig. 2(B) reaction topology. Fig. 2(C) is conﬁgured
so that substrate of the 1st pathway exerts inhibition on its own
enzyme whilst the 2nd pathway is free from enzyme inhibition.
Using these 3 separate enzyme inhibition topologies, we in-
vestigated possible roles that CI turnover plays in maintaining
metabolic homeostasis. The Fig. 2(D) reaction topology resembles
that of glycolysis, but is an intact in-vivo-like system.
2.3. The open system
Metabolism can take place only in open system. As will be
shown in the subsequent section, the Fig. 2(A) reaction topology
can be classiﬁed as an in-vivo-like system (see Section 4). With
this pre-knowledge, the effects of substrate feeding on the meta-
bolite Y1 are illustrated (Fig. 3). This “dry” experiment was desig-
nated so that the combined amount of substrate fed has been kept
the same over the total time duration regardless of the feeding
regime. When the substrate is fed at a ﬁxed rate, a low-con-
centration quasi-steady state for Y1 is observed (Fig. 3(A)). When
3 discrete feedings are made, each feeding causes a disturbance,
but the Y1 level reverts back to its quasi-steady state (Fig. 3(B)).
When all of the substrate is fed at the very outset, the Y1 level
again reverts back to its quasi-steady state (Fig. 3(C)). Over this
time duration, the Fig. 3(C) operation appears to be a batch reac-
tion system. As batch reaction is much easy to operate in practice,
in the following we will stick to this reaction modality.
Continuous stirred-tank reactor (CSTR) at steady state is an
open system, and has often been used for conducting in vivo re-
actions (Palsson, 2011; Villadsen et al., 2011, 2016). On one hand,
even though the reaction system does not have homeostasis
property, use of CSTR may lead to steady states for each inter-
mediate. Consequently, CSTR is inappropriate in our quest on the
emergence of metabolic homeostasis. On the other hand, if one is
using an in vivo system (i.e. cellular reaction system), use of CSTR
allows selecting different metabolic states by adjusting dilution
rate (another environmental factor). Unlike CSTR, the working
open system portrayed above can only reach quasi-steady state
owing to the fact that the product is not been removed.
3. Methods
Reaction mechanisms for a two-substrate enzyme reaction are:
(i) compulsory-order mechanism, (ii) random-order mechanism,
and (iii) double-displacement mechanism (Cornish-Bowden, 2012;
Fell, 1997). The mechanism adopted in this work is based on the
compulsory-order mechanism. To simplify the calculation, we re-
gard only one three-body enzyme complex, rather than two, for
each concerned enzyme. Therefore, each 2-substrate reaction en-
tails 4 elemental reaction steps. Although arbitrariness is involved
in reaction mechanism selection, it is nevertheless so that the
outcome kinetic expression formality is expected to be the same or
similar regardless of the above mechanisms (Cornish-Bowden,
2012).
Experimentally measured cofactor intermediates (i.e. CI) con-
centrations vary to some extents. On average and typically for E.
coli cells, Palsson (Palsson, 2011) listed the following ﬁgures: ATP
1.6 mM, ADP 0.29 mM, AMP 0.087 mM, NADþ 0.06 mM, NADH
0.03 mM. Speciﬁcally, for E. coli cells, Bennett et al. (2009) docu-
mented the following experimental results: ATP 9.6 mM, ADP
0.56 mM, AMP 0.28 mM, NADþ 0.083 mM, NADH 2.6 mM, NADPþ
0.0028 mM, and NADPH 0.12 mM. For yeast S. cerevisiae, Teusink
et al. (2000) reported experimental data: ATP 2.5–2.54 mM, ADP
1.31–1.33 mM, AMP 0.18–0.32 mM, NADþ 1.07–1.33 mM, and
NADH 0.3–0.48 mM. These data have been used as guidance for
considering CI pool size in this work.
Fig. 3. Effects of substrate feeding regimes on the Y1 (Fig. 2A reaction topology).
Three feeding regime are shown, where 500 mM of substrate is added over 542.5 h:
(A) continuous feeding at a ﬁxed rate of 0.902 mM/h, (B) initial substrate at
250 mM, followed by 3 discrete feedings (100 mM, 100 mM and 50 mM respec-
tively), and (C) all 500 mM substrate starts at the beginning.
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For the systems presented in Fig. 2, a set of ordinary differ-
entiation equations (ODEs) is established based on mass action law
and mass conservation on every metabolite, enzyme and enzyme
complex. These equations are simultaneously solved using Matlab
with ODE 15 s as the solver. The kinetic parameters, initial con-
ditions, and enzyme loadings used for simulation are given in
Tables S1, S2 and S3 of the Supplementary Material.
4. Results and discussion
The central theme of the present work is to testify the presence
of a property in the living cell, which emerges by interacting en-
zyme feedback inhibition with CI turnover. As the starting point,
one needs to exclude those systems where the metabolic stability
has already been achieved even though the enzyme inhibition and
CI turnover are artiﬁcially made absent. As a further point, one
needs also to exclude those systems where enzyme inhibition
alone is sufﬁcient in causing metabolic stability. To the basal sys-
tem meeting these 2 criteria, the following 3 additional situations
were then constructed: (i) the enzyme inhibition is incorporated,
(ii) the CI turnover is incorporated, and (iii) both the enzyme in-
hibition and the CI turnover are incorporated. To introduce CI
turnover effects, pertinent in-vivo-like systems were constructed.
To remove CI turnover effects, 2 approaches were designed: (i) if
present, to turn each pathway into an independent reaction (i.e. an
in vitro reference reaction), (ii) to make the CI pool size extra-
ordinarily large. Metabolic stability results (if any) out of these
situations were then compared.
4.1. The Fig. 2(A) reaction topology: single end-product inhibition, on
its own pathway
Realisation of the optimal end-product inhibition control (i.e.
the 1st pathway in Fig. 2(A)) was made decades ago (Umbarger,
1956; Umbarger and Brown, 1957; Monod, 1963). This type of in-
hibition limits accumulation of metabolic intermediates on the 1st
pathway (Savageau, 1976), but we do not have knowledge whether
low level steady state can also be established for the 2nd pathway
intermediates in Fig. 2(A).
When the only feedback inhibition is taken out, the deﬁcient
in-vivo-like system (Row 2 of Fig. 4) and its in vitro reference re-
actions (Row 4 of Fig. 4) have the same NCI and substrate/product
proﬁles, where the internal metabolites except Y3 and Y6 are at
steady states. Clearly, in the absence of enzyme inhibition, CI
turnover alone cannot lead to metabolic homeostasis.
When enzyme end-product inhibition is brought back, for the
in vitro reactions (Row 3 of Fig. 4), low level steady states are at-
tained only for the 1st pathway (i.e. for Y1, Y2 and Y3) but not for
the 2nd pathway (i.e. Y6 accumulates and Y4 is stabilized at ele-
vated level). However, when the CI turnover is incorporated with
end-product inhibition to make the in-vivo-like system, all me-
tabolic intermediates in both pathways are conﬁned at low levels
(Row 1 of Fig. 4). Indicatively, interactions between the CI turnover
and the end-product inhibition lead to metabolic homeostasis.
These interactive effects consequently constitute an emergent
property mentioned above. For this in-vivo-like system, NCI sta-
bilized levels increase with either decreasing inhibition strength or
increasing the CI pool size, or both (Fig. S1, Supplementary ma-
terial). Overall, these NCI concentrations are very low. In terms of
Fig. 4. Reaction time proﬁle comparison for the Fig. 2A network including the in-vivo-like system and its reference in vitro reactions. For in-vivo-like system, B and Q are
paired CI and start at 0.75 mM respectively, and BþQ pool of 1000 mM is regarded as extra-large. For the in vitro reference reactions, B/Q is substrate and product. Row 1: in-
vivo-like systemwith end-product inhibition; Row 2: in-vivo-like systemwithout inhibition; Row 3: in vitro reference reactions with end-product inhibition; Row 4: in vitro
reference reactions without inhibition; Row 5: in-vivo-like system with end-product inhibition, where CI pool size is extra-large; Row 6: in-vivo-like system without
inhibition, where the CI pool size is extra-large. Inhibition strength applied is high (Ki¼3.8*105).
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the present experimental technologies, measured results may well
reject a signiﬁcant change even though the effect per se is nu-
merically signiﬁcant.
In the majority of cases, it is not possible to obtain the in vitro
reference reactions out of an in-vivo-like system (e.g. the Fig. 2
(B) and (D) reaction topologies). In such cases, use of an extra-
large CI pool size (e.g. BþQ¼1000 mM) is the only alternative for
dampening or even removing the CI turnover effect. Validity of
this approach is conﬁrmed by comparing Row 2 with Row 6
(Fig. 4), and Row 3 with Row 5 (Fig. 4). The difference between
Row 1 and Row 5 (Fig. 4) indicates that metabolic homeostasis is
more likely to be associated with small CI pool size.
4.2. The Fig. 2(B) reaction topology: single end-product inhibition,
cross pathways
In the absence of enzyme inhibition, all the displayed meta-
bolites behave identically between the deﬁcient in-vivo-like sys-
tem (Row 2 in Fig. 5) and that with extra-large CI pool size (Row
4 in Fig. 5). Y1 and Y4 are stabilized but at an unacceptably high
level (i.e. 30 mM), Y2 and Y5 stabilized at a low level (i.e. 0.02 mM),
and Y3 and Y6 simply accumulate almost in a linear fashion. This
outcome conﬁrms that metabolic homeostasis cannot be achieved
without the enzyme inhibition. For the in-vivo-like system where
both the enzyme inhibition and the CI turnover are present, me-
tabolic homeostasis is satisfactorily reached (Row 1 of Fig. 5).
Quantitatively, NCI steady state concentrations for this in-vivo-like
system can be increased by reducing inhibition strength (Fig. S2A
in Supplementary material) or increasing the CI pool size (Fig. S2B,
Supplementary material), or a combination of both. In the pre-
sence of the enzyme inhibition and with the extra-large CI pool
size (Row 3 of Fig. 5), NCI concentrations on the 1st pathway (i.e.
Y1, Y2 and Y3) can be stabilized to low levels, but those on the 2nd
pathway (i.e. Y4, Y5 and Y6) cannot. In detail, Y4 is stabilized yet its
level is too high, Y5 is stabilized to a low level, and Y6 simply keeps
accumulating. Indicatively, low-level NCI steady states for the 1st
pathway are independent of the CI turnover when the CI pool size
becomes extra-large. Note that the 1st pathway has inhibition
whereas the 2nd pathway does not have. Again, the enzyme in-
hibition is essential for metabolic homeostasis, which can be
propagated to another inhibition free pathway with the aid of
small size CI turnover.
4.3. The Fig. 2(C) reaction topology: single substrate inhibition, on its
own pathway
Substrate inhibition is also important for enzyme regulation at
both gene and metabolic levels (Cornish-Bowden, 2012; Yoshino
and Murakami, 2015; Reed et al., 2010). It is therefore worth
providing evidences at the metabolic level that the emergent
property out of the CI turnover and the enzyme inhibition is also
present for this in-vivo-like system (Fig. 2(C)).
When the enzyme inhibition is absent, the corresponding NCI
proﬁles are identical between the deﬁcient in-vivo-like system,
the in vitro reference reactions, and the deﬁcient in-vivo-like
system with extra-large CI pool size (Row 2, Row 4 and Row 6 of
Fig. 6). When the substrate inhibition is introduced, (i) the in-vivo-
like system instantaneously reaches metabolic homeostasis (Row
1 of Fig. 6), (ii) for the in vitro reference reactions (Row 3 of Fig. 6),
all NCIs on the 1st pathway (Y1, Y2 and Y3) and 2 NCIs on the 2nd
pathway (Y4 and Y5) reach low-level steady states whereas Y6
keeps accumulating, (iii) the NCI proﬁles between the (deﬁcient)
in-vivo-like system with extra-large CI pool size and the in vitro
reference reactions (Row 5 and Row 3 of Fig. 6) are very similar.
These observations corroborate with conclusions made on the
2 previous in-vivo-like systems that an emergent property is ex-
hibited following interactions between the enzyme inhibition and
small pool size CI turnover. Initial substrate concentration in Fig. 6
is reduced to 5 mM (rather than 500 mM) due to the substrate
inhibition nature. This alteration however is avoided for the 2nd in
vitro reference reaction and for the 2nd pathway of the (deﬁcient)
in-vivo-like system with extra-large CI pool size (Row 3 and Row
5 of Fig. 6).
To separate the effects of enzyme inhibition and CI pool size for
the in-vivo-like system, it is observed that (i) high enzyme in-
hibition strength does not noticeably reduce steady state NCI
concentrations (Fig. S3A, Supplementary material), (ii) alteration
of CI pool size does not noticeably affect NCIs levels on the 1st
pathway whereas a reduction in CI pool size can result in a further
decrease of NCI levels on the 2nd pathway (Fig. S3B, Supplemen-
tary material). These properties for this in-vivo-like system (Fig. 2
(C)) are different to those for the other 2 in-vivo-like systems (i.e.
Fig. 5. Reaction time proﬁle comparison for the Fig. 2B network. For in-vivo-like system, B and Q are paired CI and start at 0.75 mM respectively, BþQ pool of 1000 mM is
regarded as extra-large. Row 1: in-vivo-like system with cross-pathway end-product inhibition; Row 2: in-vivo-like system without inhibition; Row 3: in-vivo-like system
with cross-pathway end-product inhibition, where the CI pool size is extra-large; Row 4: in-vivo-like system without inhibition, where the CI pool size is extra-large.
Inhibition strength applied is high (Ki¼3.8*105).
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Fig. 2(A) and (B), in Supplementary material). As the NCI levels in
these 3 in-vivo-like systems are unanimously low, effects of en-
zyme inhibition and CI pool size on NCI concentrations are likely
to be practically insigniﬁcant in response to environmental chan-
ges. These results might underpin the well-observed metabolic
robustness (Kitano, 2007; Stephanopoulos and Vallino, 1991).
4.4. Fig. 2(A)–(C): metabolic stability propagation from one pathway
to the other
When the difference is only on inhibition topology (Fig. 2: A, B
and C), the 3 in-vivo-like systems achieve metabolic homeostasis
all based on the interaction between enzyme inhibition and CI
turnover. When the enzyme inhibition is taken away, NCIs on both
pathways of any system lose low-level steady states. When one
signiﬁcantly dampens the CI turnover effect, only NCIs on the 1st
pathway of any system remain to have low-level steady states. This
speciﬁc outcome is consistent with the existing knowledge that
enzyme feedback control can avoid metabolite build-up (see Sec-
tion 1).
4.5. The Fig. 2(D) reaction topology: branched network
When considering in-vivo-like systems containing branched
backbone pathways, the Fig. 2(D) reaction topology has been used
to explain establishment of spontaneous metabolic homeostasis.
This example entails B1/Q1 and B2/Q2 to resemble ATP/ADP and
NADþ/NADH in glycolysis. To globally balance the CI turnovers, an
overall biomass (X) production “pathway” is introduced. This in-
vivo-like system does not have reference in vitro reactions, and so
extra-large CI pool size is used to remove the CI turnover effects.
Without enzyme inhibition, most NCIs (i.e. Y3, Y4, Y7, Y8, Y10,
Y11 and Y12) cannot be stabilized to low levels in this deﬁcient in-
vivo-like system, and so the system is unable to reach metabolic
homeostasis (Fig. 7(B)). In contrast, the in-vivo-like system with
the end-product inhibition acquires instantaneous metabolic
homeostasis (Fig. 7(A)). When the B1þQ1 pool size for the in-vivo-
like system is increased to extra-large, the NCI proﬁles show de-
cent similarities to the deﬁcient in-vivo-like system where the
enzyme inhibition is absent (Fig. 7(B) vs (C)). As before, the in-
vivo-like system with extra-large CI pool size (Fig. 7(C)) cannot
spontaneously reach metabolic homeostasis. However, metabolic
homeostasis for the in-vivo-like system is not affected when the
Fig. 6. Reaction time proﬁle comparison for the Fig. 2C network including the in-vivo-like system and its reference in vitro reactions. For in-vivo-like system, B and Q are
paired CI and start at 0.75 mM respectively, BþQ pool of 1000 mM is regarded as extra-large. For the in vitro reference reaction, B/Q is substrate and product. Row 1: in-vivo-
like system with substrate inhibition; Row 2: in-vivo-like system without inhibition; Row 3: in vitro reactions with substrate inhibition; Row 4: in vitro reactions without
inhibition; Row 5: in-vivo-like system with substrate inhibition, where CI pool size is extra-large; Row 6: in-vivo-like system without inhibition, where CI pool size is extra-
large. Inhibition strength applied is high (Ki¼3.8*105).
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B2þQ2 pool size is increased to extra-large (Fig. 7(D) vs (A)). On
one hand, it is the B1/Q1 turnover with the end-product inhibition
that contributes to homeostasis establishment. On the other hand,
this homeostasis-forming property does not emerge from those CI
turnover topologies in which the concerned NCI ﬂux(es) has(have)
no inﬂuence on the overall CI balance. For instance, B2/Q2 in the
Fig. 2(D) topology has been shown to balance their turnover un-
conditionally. Except linear pathways, it can be difﬁcult to visually
identify such CI turnover topologies.
With regards to the inﬂuence on NCIs in this in-vivo-like sys-
tem, an increase of the end-product inhibition strength (Fig. S4A,
Supporting material) or a decrease of the B1þQ1 pool size (Fig.
S4B, Supporting material) slightly suppresses their steady-state
concentrations. However, a change in the B2þQ2 pool size has
little effects on their steady-state concentrations (Fig. S4C, Sup-
porting material). This is consistent with the above analysis that
no emergent property is present between the end-product in-
hibition and the B2/Q2 turnover.
4.6. Comments on in vivo, in-vivo-like, and in vitro systems
A clear intention of the present work is to uncover reaction
topologies used by living cells to maintain their intracellular me-
tabolic reactions at homeostasis. Understanding of such mechan-
isms would allow us to construct perhaps simpliﬁed multi-enzyme
reaction systems to possess at least certain cellular reaction
properties such as steady state or low-level steady state for NCIs. It
is important to stress that not all multi-enzyme reaction systems
with CI turnover are in-vivo-like systems. Indeed, most of the
experimentally explored remain to be in vitro systems rather than
in-vivo-like systems (e.g. Rollin et al., 2015). We will compare both
pros and cons of in vitro and in-vivo-like systems in the
forthcoming publications.
A foundation in reasoning in-vivo-like systems is based upon
the spontaneous robustness of any such systems in response to
drastic environmental changes. The results we used for illustration
(Fig. 3) may seem to be speciﬁc, but it is obvious to us that such
property is generic for any in vivo and thus in-vivo-like systems.
Further work is under way in our group to provide evidence in a
more systematic fashion.
5. Conclusion
Based on simple but characteristic metabolic reaction systems,
this work has identiﬁed a fundamental mechanism that con-
tributes to the establishment of metabolic stability at metabolic
level (i.e. typical time scale of 0.1–1 s). This mechanism has been
phrased as follows: located rather evenly in the metabolic net-
work, CIs participate in most reactions and turnover globally using
a ﬁxed and small pool size. Working with enzyme feedback in-
hibition for the in vivo metabolic reaction topology, omnipresence
of CIs and their balanced turnovers contribute to establish meta-
bolic homeostasis.
By separating global turnover of the paired CIs from the carbon
backbone metabolic ﬂux for each reaction topology, we have
identiﬁed that low-concentration steady states for NCIs are able to
propagate from one pathway to the other. By contrast, metabolic
ﬂux analysis and the likes have always been based on the prior
assumption that metabolic homeostasis had already been there. In
our view, this is the reason why this unique property concerning CI
turnover had not been discovered before. Broadly speaking, this
work offers a new perspective for understanding the role of co-
factor intermediates [e.g. the energy metabolism (Atkinson, 1968)]
Fig. 7. Reaction time proﬁle comparison for the Fig. 2D network topology. B1 and Q1 are paired and each starts at 0.75 mM for their normal pool size. B2 and Q2 are paired
and each starts at 0.4 mM for their normal pool size. B1þQ1 pool of 1500 mM, and B2þQ2 pool of 8000 mM, are regarded as extra-large. Inhibition strength applied is high
(Ki¼3.8*104).
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and the presence of metabolic homeostasis in the living cell.
Speciﬁcally, this work might provide clues for constructing non-
natural metabolic networks either using multi-enzyme reactions
or by degenerating metabolic reaction networks from the living
cell.
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